期刊文献+

清肝解郁方对偏头痛患者生活质量的影响 被引量:9

Qinggan Jieyu Granule on quality of life of patients with migraine
下载PDF
导出
摘要 目的评价清肝解郁方治疗肝郁化热证偏头痛患者的临床疗效及对患者生活质量的影响。方法采用随机对照的设计方法,共纳入符合入组标准的60例患者,治疗组服用清肝解郁方免煎颗粒,对照组服用天舒胶囊,疗程均为4周。分别于治疗前后对患者生活质量及头痛发作次数、天数进行评价。结果 1)治疗后,2组患者SF-36生活质量各条目得分均较治疗前提高,且治疗组提高更明显,条目活力(VT)组间比较差异有统计学意义(P<0.05);2)治疗前后,2组生活质量各条目得分差值的组间比较,心理健康(MH)、社会功能(SF)、活力(VT)及总体健康(GH)具有统计学意义;3)治疗前后2组头痛发作次数、天数差值的组间比较,差异有统计学意义(P<0.05)。结论清肝解郁方能显著提高肝郁化热证偏头痛患者的生活质量,且能减少头痛发作的次数和天数。 Objective To investigate the effects of Qinggan Jieyu Granule in the improvement of the quality of life in patients with migraine. Methods Using the SF-36 scale of Chinese version,we investigated the life quality of 60 migraine patients. The treatment group was given Qinggan Jieyu Granule and the control group was given Tianshu capsule. Life quality,migraine attack frequency and the days of migraine attacks were evaluated before and after the treatment respectively. Results After 4 weeks' treatment,the quality of life was improved in both groups,more obvious in the treatment group,vitality(VT) has statistical significance between groups(P 0. 05). In contrast of deviations of each item between the two groups,mental health(MH),social function(SF),vitality(VT) and general health(GH)had statistical difference. The deviation of migraine attacks and migraine days before and after the treatment had statistical difference(P 0. 05). Conclusion Qinggan Jieyu Granule can improve the quality life of migraine patients and reduce the migraine attack frequency and the days of migraine attacks.
出处 《吉林中医药》 2016年第8期780-783,共4页 Jilin Journal of Chinese Medicine
基金 北京中医药大学创新团队项目(2011-CXTD-22) 国家自然科学基金课题(81273688)
关键词 偏头痛 肝郁化热证 清肝解郁方 生活质量 SF-36量表 Migraine stagnation of liver and heat qinggan Jieyu Granule quality of life SF-36 scale
  • 相关文献

参考文献20

  • 1BURCH R C,LODER S,LODER E,et al.The prevalence andburden of migraine and severe headache in the United States:updated statistics from government health surveillance studies[J].Headache,2015,55(1): 21-34. 被引量:1
  • 2MURRAY C J,LOPEZ A D.Mortality by cause for eight re-gions of the world: Global Burden of Disease Study[J].Lan-cet,1997,349: 1269-1276. 被引量:1
  • 3STEINER T J,STOVNER L J,BIRBECK G L.Migraine: theseventh disabler[J].Headache,2013,53 (2 ): 227-229.DOI:10.1111 / head.12034. 被引量:1
  • 4LODER S,SHEIKH H U,LODER E.The prevalence,burden,and treatment of severe,frequent,and migraine headaches inUS minority populations: statistics from National Survey stud-ies[J].Headache,2015,55(2): 214-228. 被引量:1
  • 5LIU R,YU S,HE M,et al.Health-care utilization for primaryheadache disorders in China: a population-based door-to-doorsurvey[J].J Headache Pain,2013,14: 47. 被引量:1
  • 6STOVNER L J,HAGEN K,JENSEN R,et al.The global bur-den of headache: a documentation of headache prevalence anddisability worldwide[J].Cephalalgia,2007,27(3): 193-210. 被引量:1
  • 7BURCH R C,LODER S,LODER E,et al.The prevalence andburden of migraine and severe headache in the United States:updated statistics from government health surveillance studies[J].Headache,2015,55(1): 21-34. 被引量:1
  • 8VOS T,FLAXMAN A D,NAGHAVI M,et al.Years lived withdisability (YLDs) for 1160 sequelae of 289 diseases and inju-ries 1990-2010: a systematic analysis for the Global Burden ofDisease Study 2010[J].Lancet,2012,380(9859): 2163-2196. 被引量:1
  • 9LIPTON R B,STEWART W F,DIAMOND S,et al.Prevalenceand burden of migraine in the United States: data from the Amer-ican Migraine Study II[J].Headache,2001,41(7): 646-657. 被引量:1
  • 10AYZENBERG I,KATSARAVA Z,SBOROWSKI A,et al.Head-ache-attributed burden and its impact on productivity and qual-ity of life in Russia: structured healthcare for headache is ur-gently needed[J].Eur J Neurol,2014,21(5): 758-765. 被引量:1

二级参考文献27

  • 1王阶,李军,杨戈,姚魁武.冠心病心绞痛病证结合的证候诊断量表的制订思路与方法[J].世界科学技术-中医药现代化,2007,9(3):13-17. 被引量:10
  • 2Osterhaus JT,Townsend R J,Gandek B,et al.Measuring the functional status and well-being of patients with migraine headache.Headache,1994,34:337-343. 被引量:1
  • 3Freitag F,Smith T,Mathew N,et al.Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability:results from the AEGIS Trial.Headache,2008,48:341-354. 被引量:1
  • 4Headache Classification Subcommittee of the International Headache Society.The International Classification of Headache Disorders:2nd edition.Cephalalgia,2004,24(Suppl 1):9-160. 被引量:1
  • 5Guyatt GH,Feeny DH,Patrick DL.Measuring health-related quality of life.Ann Intern Med,1993,118:622-629. 被引量:1
  • 6Brandes JL.The migraine cycle:patient burden of migraine during and between migraine attacks.Headache,2008,48:430-441. 被引量:1
  • 7Wang SJ,Fuh JL,Lu SR,et al.Quality of life differs among headache diagnoses:analysis of SF-36 survey in 901 headache patients.Pain,2001,89:285-292. 被引量:1
  • 8Lipton RB,Liberman JN,Kolodner KB,et al.Migraine headache disability and health-related quality-of-life:a population-based case-control study from England.Cephalalgia,2003,23:441-450. 被引量:1
  • 9Terwindt GM,Ferrari MD,Tijhuis M,et al.The impact of migraine on quality of life in the general population:the GEM study.Neurology,2000,55:624-629. 被引量:1
  • 10D'mico D,Solari A,Usai S,et al.Improvement in quality of life and activity limitations in migraine patients after prophylaxis.Cephalalgia,2006,26:691-696. 被引量:1

共引文献100

同被引文献72

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部